跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
LACOSAMIDA ALEMBIC 150 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
LACOSAMIDA ALEMBIC 150 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Approved
STANDARD
LACOSAMIDA ALEMBIC 150 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Alembic Pharmaceuticals Europe Limited
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Feb 22, 2021
Approval ID
3a546dd5921f0857
Company
Alembic Pharmaceuticals Europe Limited
Type
Standard
Approval Details
Approval Id
3a546dd5921f0857
Drug Cima Aemps Name
LACOSAMIDA ALEMBIC 150 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Register Number
85797
Holder Company Name
Alembic Pharmaceuticals Europe Limited
Marketing Company Name
Alembic Pharmaceuticals Europe Limited
Authorization Date
2021-02-22
Dosage Form
COMPRIMIDO RECUBIERTO CON PELÍCULA
Dose
150 mg
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
No
Company Name
Alembic Pharmaceuticals Europe Limited
Active Ingredients
LACOSAMIDA
150 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Feb 22, 2021
Approval ID
3a546dd5921f0857
Type
Standard
Back to CIMA-AEMPS Approvals